We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
GPX3
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • GPX3
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

GPX3 is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 358.06
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 612.1
Number of samples 362
Samples
Sample Description pTPM
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 7154.9
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 4798.0
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 3985.3
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 3651.7
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 2908.1
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 2725.6
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 2554.1
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 2457.5
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 2367.2
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 2274.6
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 2156.6
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 2121.3
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 2103.2
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 1966.1
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 1959.7
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 1932.7
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 1897.5
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 1850.9
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 1774.1
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 1740.8
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 1679.1
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 1664.6
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 1661.3
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 1626.4
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 1590.6
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 1579.5
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 1573.9
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 1416.0
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 1402.1
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 1388.1
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 1382.4
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 1366.0
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 1345.6
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 1335.7
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 1334.6
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 1301.5
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 1285.3
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 1222.5
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 1198.2
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 1146.2
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 1144.8
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 1134.2
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 1132.5
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 1130.8
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 1117.1
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 1114.4
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 1092.3
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 1081.5
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 1047.8
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 1023.7
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 1017.9
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 1009.7
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 977.5
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 973.9
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 973.1
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 967.2
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 946.9
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 937.6
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 934.8
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 928.2
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 922.2
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 915.7
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 907.1
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 906.5
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 900.3
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 892.7
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 888.3
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 888.0
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 885.4
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 881.0
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 870.1
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 859.6
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 857.2
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 848.0
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 843.1
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 826.4
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 818.2
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 818.1
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 811.2
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 808.2
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 799.5
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 790.8
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 786.6
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 773.2
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 768.5
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 768.1
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 767.2
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 762.7
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 753.9
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 753.7
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 750.3
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 747.4
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 740.8
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 735.5
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 731.6
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 728.4
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 722.7
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 721.1
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 719.5
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 713.0
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 710.5
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 706.6
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 700.7
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 696.8
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 689.0
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 688.2
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 681.6
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 680.7
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 665.3
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 659.3
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 648.5
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 644.5
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 641.0
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 639.7
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 638.1
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 637.2
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 635.9
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 634.9
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 629.1
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 622.4
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 612.8
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 610.8
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 609.4
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 609.3
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 607.5
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 605.3
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 603.9
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 603.7
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 600.7
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 600.3
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 592.9
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 591.9
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 584.3
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 581.1
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 577.3
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 572.9
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 570.1
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 559.9
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 556.4
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 554.6
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 547.1
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 546.5
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 546.2
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 539.5
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 538.7
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 533.4
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 526.2
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 525.3
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 522.6
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 515.4
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 514.7
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 513.5
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 512.0
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 509.8
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 491.4
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 487.0
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 486.2
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 486.1
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 485.4
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 482.9
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 481.9
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 480.9
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 480.0
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 467.2
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 467.1
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 465.9
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 461.5
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 458.2
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 456.2
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 454.1
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 443.8
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 439.1
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 436.8
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 436.0
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 434.4
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 433.8
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 432.2
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 430.6
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 426.0
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 425.5
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 421.4
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 420.5
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 419.1
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 414.8
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 414.0
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 412.5
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 410.4
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 407.5
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 401.8
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 399.8
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 397.0
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 384.2
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 384.0
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 378.1
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 375.6
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 373.6
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 373.5
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 373.0
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 366.4
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 364.5
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 362.2
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 361.6
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 358.1
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 353.8
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 352.1
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 350.2
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 347.0
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 346.2
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 345.7
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 343.4
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 339.9
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 339.6
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 335.2
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 334.4
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 334.3
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 333.7
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 333.6
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 333.4
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 332.4
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 330.5
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 330.4
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 330.1
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 324.5
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 324.3
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 324.2
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 322.8
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 322.5
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 318.9
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 315.1
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 311.1
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 310.3
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 309.4
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 307.9
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 307.7
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 306.3
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 305.9
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 304.3
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 303.8
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 303.0
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 302.8
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 301.0
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 288.2
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 287.9
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 286.9
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 286.1
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 284.6
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 283.8
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 282.3
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 277.9
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 276.8
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 271.4
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 268.3
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 266.6
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 263.6
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 261.2
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 259.5
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 259.3
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 258.9
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 255.8
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 255.2
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 254.3
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 252.6
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 249.4
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 247.4
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 245.3
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 243.6
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 241.8
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 240.0
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 238.8
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 236.3
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 231.1
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 230.3
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 228.0
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 226.2
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 225.7
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 224.5
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 222.3
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 220.3
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 218.9
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 215.4
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 214.0
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 213.6
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 213.4
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 210.1
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 207.9
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 207.7
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 207.3
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 206.5
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 204.3
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 204.1
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 202.1
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 194.6
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 192.3
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 187.3
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 186.0
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 183.4
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 183.0
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 181.0
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 180.1
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 177.3
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 176.0
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 169.2
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 168.3
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 159.9
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 159.6
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 159.4
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 157.9
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 155.5
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 154.4
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 147.9
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 144.6
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 142.9
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 142.5
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 139.2
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 138.5
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 138.4
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 138.0
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 130.6
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 129.6
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 126.9
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 125.7
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 121.3
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 120.0
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 113.7
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 112.7
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 111.2
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 110.5
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 110.0
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 103.4
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 103.0
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 100.9
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 98.5
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 97.7
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 97.6
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 97.6
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 96.4
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 95.6
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 80.7
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 77.4
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 75.6
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 71.9
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 71.5
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 71.4
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 68.3
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 66.3
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 65.1
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 60.4
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 57.4
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 56.7
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 56.3
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 54.2
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 54.2
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 53.9
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 51.8
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 40.1
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 38.9
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 38.8
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 38.6
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 29.3
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 17.5
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 14.4
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 6.4
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

GPX3 is not prognostic in Liver Hepatocellular Carcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 1071.45
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 789.2
Number of samples 231
Samples
Sample Description pTPM
DO45091 56 years, male, NA, stage:2, dead, 1320 days 5956.3
DO48693 71 years, male, NA, stage:2, alive, 900 days 3873.2
DO45149 70 years, female, NA, stage:2, alive, 1260 days 3620.5
DO23545 67 years, male, NA, stage:2, dead, 570 days 3473.1
DO23511 83 years, female, NA, stage:3, dead, 180 days 3092.8
DO50857 72 years, male, NA, stage:2, alive, 210 days 3091.7
DO50811 62 years, male, NA, stage:1, alive, 450 days 2869.3
DO45169 74 years, male, NA, stage:3, alive, 1350 days 2775.6
DO23516 69 years, male, NA, stage:3, dead, 20 days 2536.5
DO23518 67 years, male, NA, stage:2, alive, 1320 days 2483.2
DO45092 62 years, male, NA, stage:4, dead, 1200 days 2339.5
DO48706 72 years, male, NA, stage:2, alive, 870 days 2159.8
DO48679 72 years, male, NA, stage:2, alive, 1200 days 2025.5
DO45105 61 years, male, NA, stage:1, alive, 1680 days 2002.3
DO48716 71 years, male, NA, stage:2, alive, 720 days 1977.2
DO50817 75 years, male, NA, stage:2, alive, 390 days 1949.1
DO23533 61 years, male, NA, stage:2, alive, 900 days 1941.8
DO50816 63 years, male, NA, stage:2, alive, 390 days 1903.7
DO45163 76 years, male, NA, stage:2, alive, 960 days 1860.7
DO23512 60 years, male, NA, stage:1, alive, 1260 days 1765.2
DO50839 47 years, female, NA, stage:3, alive, 330 days 1721.7
DO45119 74 years, male, NA, stage:3, dead, 510 days 1706.0
DO45113 58 years, male, NA, stage:3, alive, 1560 days 1671.8
DO45131 53 years, male, NA, stage:4, dead, 360 days 1660.7
DO45167 67 years, male, NA, stage:2, dead, 1440 days 1628.9
DO45133 64 years, male, NA, stage:3, dead, 660 days 1514.2
DO45117 73 years, female, NA, stage:2, dead, 1110 days 1493.7
DO23548 78 years, female, NA, stage:1, alive, 840 days 1481.8
DO50822 66 years, male, NA, stage:2, alive, 510 days 1416.1
DO50798 77 years, male, NA, stage:3, dead, 30 days 1414.0
DO45197 51 years, male, NA, stage:2, alive, 1170 days 1368.0
DO45097 69 years, male, NA, stage:3, alive, 1620 days 1367.7
DO45095 66 years, male, NA, stage:2, alive, 1620 days 1341.5
DO45267 73 years, male, NA, stage:3, dead, 570 days 1338.1
DO48746 76 years, male, NA, stage:3, alive, 570 days 1329.9
DO45094 76 years, male, NA, stage:3, alive, 1650 days 1313.1
DO50814 83 years, male, NA, stage:3, alive, 420 days 1310.8
DO23509 60 years, male, NA, stage:3, dead, 780 days 1297.3
DO50859 77 years, male, NA, stage:2, alive, 180 days 1270.1
DO23538 67 years, male, NA, stage:2, alive, 450 days 1269.8
DO45273 62 years, male, NA, stage:2, alive, 480 days 1237.9
DO50783 62 years, male, NA, stage:3, alive, 480 days 1220.6
DO50800 74 years, male, NA, stage:2, alive, 510 days 1198.1
DO45127 73 years, male, NA, stage:3, dead, 420 days 1189.1
DO23508 79 years, female, NA, stage:2, alive, 390 days 1176.1
DO50778 60 years, male, NA, stage:4, alive, 630 days 1168.5
DO45255 81 years, male, NA, stage:3, alive, 720 days 1161.6
DO48672 81 years, male, NA, stage:2, alive, 450 days 1152.5
DO48733 72 years, male, NA, stage:2, alive, 600 days 1144.1
DO48677 58 years, male, NA, stage:3, alive, 1140 days 1135.7
DO45115 81 years, male, NA, stage:2, alive, 840 days 1133.2
DO48723 73 years, male, NA, stage:1, alive, 600 days 1114.9
DO48742 76 years, male, NA, stage:2, alive, 600 days 1101.5
DO45096 69 years, male, NA, stage:2, dead, 1290 days 1093.3
DO23539 77 years, male, NA, stage:1, alive, 1110 days 1089.3
DO45103 47 years, male, NA, stage:3, alive, 450 days 1083.0
DO45217 69 years, female, NA, stage:3, dead, 270 days 1071.7
DO45141 73 years, male, NA, stage:2, alive, 1320 days 1071.2
DO45215 65 years, male, NA, stage:2, alive, 1170 days 1048.8
DO45101 63 years, male, NA, stage:2, alive, 1680 days 1011.8
DO45175 74 years, male, NA, stage:2, alive, 1140 days 1008.6
DO23546 63 years, male, NA, stage:2, alive, 1050 days 998.8
DO50804 81 years, male, NA, stage:2, alive, 720 days 987.7
DO45111 74 years, male, NA, stage:2, alive, 1590 days 983.6
DO23530 53 years, male, NA, stage:4, dead, 180 days 960.0
DO45257 46 years, male, NA, stage:3, alive, 810 days 942.6
DO50793 76 years, male, NA, stage:4, alive, 540 days 923.1
DO45093 71 years, male, NA, stage:2, dead, 720 days 919.1
DO23543 63 years, male, NA, stage:2, alive, 1020 days 917.4
DO45173 63 years, male, NA, stage:3, alive, 1170 days 904.3
DO48759 73 years, male, NA, stage:3, alive, 720 days 891.0
DO45233 83 years, male, NA, stage:3, alive, 900 days 883.9
DO45109 63 years, male, NA, stage:2, alive, 1590 days 878.4
DO48681 57 years, male, NA, stage:2, alive, 900 days 871.4
DO45221 75 years, female, NA, stage:4, dead, 390 days 870.4
DO23532 71 years, female, NA, stage:1, alive, 960 days 868.7
DO45201 49 years, male, NA, stage:1, alive, 900 days 865.0
DO45159 65 years, male, NA, stage:3, alive, 1470 days 860.9
DO45107 63 years, female, NA, stage:2, alive, 1710 days 859.2
DO45157 62 years, male, NA, stage:2, alive, 1980 days 855.9
DO50789 73 years, female, NA, stage:2, alive, 570 days 847.8
DO45099 46 years, male, NA, stage:3, alive, 1590 days 807.1
DO45153 77 years, female, NA, stage:2, alive, 1380 days 805.8
DO23528 45 years, female, NA, stage:2, alive, 1020 days 794.9
DO23525 71 years, male, NA, stage:4, alive, 1050 days 784.5
DO45223 67 years, male, NA, stage:4, alive, 1020 days 778.6
DO45241 49 years, male, NA, stage:1, alive, 1080 days 767.8
DO23524 71 years, female, NA, stage:2, alive, 1050 days 759.4
DO48695 77 years, male, NA, stage:2, alive, 720 days 741.6
DO48760 70 years, female, NA, stage:2, alive, 690 days 740.5
DO227643 79 years, male, NA, stage:2, alive, 1260 days 737.3
DO50774 68 years, female, NA, stage:2, alive, 720 days 735.3
DO48743 69 years, female, NA, stage:2, alive, 570 days 734.6
DO45161 74 years, male, NA, stage:2, dead, 540 days 729.9
DO48757 68 years, female, NA, stage:3, alive, 480 days 729.9
DO23541 65 years, male, NA, stage:2, alive, 930 days 724.9
DO50805 72 years, male, NA, stage:2, alive, 690 days 724.4
DO48737 52 years, male, NA, stage:1, alive, 720 days 716.8
DO45229 74 years, male, NA, stage:1, alive, 990 days 707.8
DO50818 65 years, male, NA, stage:2, alive, 510 days 701.7
DO45261 74 years, male, NA, stage:3, alive, 990 days 698.4
DO45235 68 years, female, NA, stage:1, alive, 900 days 683.3
DO50819 72 years, female, NA, stage:2, alive, 510 days 665.0
DO50806 70 years, male, NA, stage:4, alive, 540 days 650.5
DO50829 78 years, male, NA, stage:3, alive, 570 days 648.6
DO45213 58 years, male, NA, stage:1, alive, 1200 days 647.8
DO50803 62 years, female, NA, stage:1, alive, 540 days 646.2
DO23527 72 years, male, NA, stage:1, alive, 1050 days 640.6
DO45143 69 years, male, NA, stage:3, alive, 1290 days 638.2
DO23551 73 years, male, NA, stage:3, dead, 150 days 631.0
DO50776 75 years, male, NA, stage:1, alive, 690 days 630.1
DO23523 52 years, male, NA, stage:3, alive, 1080 days 626.9
DO45195 62 years, male, NA, stage:1, alive, 390 days 624.3
DO48704 68 years, female, NA, stage:3, alive, 750 days 609.1
DO45253 50 years, male, NA, stage:2, alive, 870 days 606.0
DO48700 78 years, female, NA, stage:2, alive, 810 days 602.1
DO50845 72 years, male, NA, stage:3, alive, 210 days 596.2
DO50825 70 years, male, NA, stage:2, alive, 390 days 594.2
DO23519 65 years, male, NA, stage:3, alive, 630 days 588.6
DO50785 37 years, male, NA, stage:4, dead, 90 days 585.2
DO45207 68 years, male, NA, stage:1, alive, 1050 days 581.7
DO45177 81 years, female, NA, stage:3, alive, 1260 days 578.9
DO45135 77 years, male, NA, stage:1, alive, 1410 days 578.0
DO45193 68 years, female, NA, stage:4, dead, 120 days 574.2
DO45281 83 years, male, NA, stage:4, alive, 750 days 570.0
DO23536 56 years, male, NA, stage:2, alive, 930 days 556.0
DO50799 66 years, female, NA, stage:2, alive, 540 days 553.7
DO227801 77 years, female, NA, stage:1, alive, 660 days 552.9
DO45125 58 years, male, NA, stage:3, alive, 1680 days 543.6
DO48701 78 years, male, NA, stage:2, alive, 780 days 527.0
DO45165 75 years, male, NA, stage:2, alive, 690 days 523.4
DO45181 84 years, female, NA, stage:2, alive, 1200 days 522.6
DO50809 56 years, male, NA, stage:3, dead, 720 days 513.5
DO45225 69 years, male, NA, stage:1, alive, 1050 days 511.3
DO23540 73 years, male, NA, stage:1, alive, 750 days 477.8
DO45187 32 years, female, NA, stage:1, alive, 1260 days 477.3
DO45121 61 years, male, NA, stage:3, alive, 1530 days 474.2
DO50850 74 years, male, NA, stage:3, alive, 720 days 470.7
DO23542 66 years, male, NA, stage:3, alive, 960 days 465.1
DO23550 69 years, male, NA, stage:1, alive, 990 days 458.5
DO45249 57 years, male, NA, stage:1, alive, 630 days 452.3
DO23535 67 years, male, NA, stage:1, alive, 960 days 448.9
DO23510 80 years, female, NA, stage:2, alive, 870 days 447.1
DO45227 57 years, female, NA, stage:2, alive, 1020 days 444.8
DO23544 67 years, male, NA, stage:2, alive, 960 days 436.9
DO48712 50 years, male, NA, stage:2, alive, 810 days 430.3
DO48721 58 years, female, NA, stage:1, alive, 900 days 428.7
DO45191 61 years, female, NA, stage:2, alive, 1200 days 428.0
DO45129 61 years, male, NA, stage:3, alive, 1470 days 426.9
DO48741 64 years, male, NA, stage:3, alive, 240 days 421.9
DO23547 74 years, male, NA, stage:1, alive, 1020 days 404.1
DO48725 66 years, male, NA, stage:1, alive, 780 days 402.5
DO48715 58 years, female, NA, stage:2, dead, 690 days 397.5
DO45139 63 years, male, NA, stage:3, alive, 1320 days 397.4
DO50808 68 years, male, NA, stage:2, alive, 570 days 369.8
DO50855 47 years, male, NA, stage:2, alive, 570 days 353.4
DO45171 56 years, male, NA, stage:3, alive, 600 days 349.8
DO45239 42 years, male, NA, stage:2, alive, 870 days 336.8
DO45219 78 years, male, NA, stage:2, alive, 1080 days 336.3
DO50787 63 years, male, NA, stage:3, alive, 480 days 330.5
DO45265 73 years, male, NA, stage:3, alive, 1020 days 327.3
DO23537 79 years, male, NA, stage:2, dead, 900 days 317.6
DO48730 73 years, female, NA, stage:2, alive, 630 days 315.3
DO48697 64 years, female, NA, stage:2, dead, 810 days 313.0
DO45231 84 years, male, NA, stage:2, alive, 930 days 312.3
DO45123 78 years, female, NA, stage:2, dead, 570 days 307.2
DO45137 38 years, male, NA, stage:1, alive, 1320 days 305.9
DO23531 78 years, female, NA, stage:3, alive, 900 days 295.7
DO23514 64 years, male, NA, stage:2, alive, 1290 days 295.3
DO48717 54 years, male, NA, stage:4, dead, 180 days 293.2
DO48747 62 years, male, NA, stage:3, alive, 540 days 293.0
DO45247 31 years, female, NA, stage:2, alive, 210 days 284.4
DO45275 65 years, male, NA, stage:3, dead, 10 days 281.7
DO23552 80 years, female, NA, stage:1, alive, 810 days 280.5
DO45203 71 years, female, NA, stage:2, alive, 1170 days 271.9
DO45183 72 years, female, NA, stage:2, dead, 570 days 266.7
DO45199 86 years, female, NA, stage:2, alive, 1350 days 265.0
DO50791 79 years, female, NA, stage:1, dead, 480 days 262.8
DO45263 67 years, male, NA, stage:3, dead, 270 days 261.1
DO45145 78 years, male, NA, stage:3, dead, 60 days 257.2
DO48674 80 years, male, NA, stage:2, alive, 1260 days 257.1
DO48732 73 years, male, NA, stage:3, alive, 630 days 253.6
DO48720 62 years, female, NA, stage:2, alive, 570 days 251.9
DO48761 55 years, male, NA, stage:2, alive, 870 days 237.7
DO45269 59 years, male, NA, stage:3, alive, 750 days 237.3
DO50820 77 years, female, NA, stage:3, alive, 510 days 233.9
DO50802 49 years, male, NA, stage:2, alive, 930 days 230.3
DO23517 62 years, male, NA, stage:2, alive, 1200 days 227.9
DO23534 60 years, male, NA, stage:2, alive, 840 days 225.1
DO50813 56 years, male, NA, stage:2, alive, 420 days 216.9
DO50815 62 years, male, NA, stage:3, alive, 150 days 215.5
DO50807 67 years, male, NA, stage:1, alive, 540 days 213.7
DO45179 78 years, female, NA, stage:2, alive, 600 days 213.4
DO48728 74 years, female, NA, stage:2, alive, 150 days 207.2
DO23513 76 years, male, NA, stage:3, alive, 1200 days 202.0
DO45155 69 years, male, NA, stage:2, alive, 2160 days 194.8
DO45301 56 years, male, NA, stage:2, dead, 1440 days 191.9
DO48736 76 years, female, NA, stage:1, alive, 600 days 178.1
DO23549 74 years, male, NA, stage:3, alive, 990 days 172.7
DO23526 66 years, male, NA, stage:3, alive, 1050 days 172.6
DO45243 74 years, female, NA, stage:3, alive, 930 days 162.0
DO45209 70 years, male, NA, stage:4, alive, 1350 days 155.2
DO45283 60 years, male, NA, stage:3, alive, 510 days 153.3
DO48751 68 years, male, NA, stage:2, dead, 480 days 144.0
DO45251 57 years, female, NA, stage:2, alive, 900 days 141.1
DO50832 73 years, male, NA, stage:3, alive, 90 days 137.3
DO50840 49 years, male, NA, stage:2, alive, 330 days 129.4
DO45277 64 years, male, NA, stage:3, alive, 600 days 124.4
DO50844 75 years, male, NA, stage:4, alive, 300 days 120.3
DO48682 72 years, female, NA, stage:3, dead, 120 days 118.1
DO45185 89 years, male, NA, stage:2, alive, 600 days 105.1
DO45307 54 years, female, NA, stage:4, dead, 240 days 104.0
DO23515 71 years, male, NA, stage:2, alive, 1230 days 100.4
DO45287 74 years, male, NA, stage:1, alive, 390 days 86.6
DO48727 81 years, female, NA, stage:2, dead, 390 days 79.3
DO23521 63 years, male, NA, stage:3, alive, 1110 days 75.9
DO45305 66 years, male, NA, stage:4, alive, 300 days 65.5
DO45303 62 years, female, NA, stage:3, alive, 990 days 58.4
DO45189 85 years, female, NA, stage:2, alive, 1200 days 56.0
DO45237 58 years, male, NA, stage:2, alive, 900 days 53.4
DO48719 80 years, male, NA, stage:2, alive, 690 days 43.6
DO45279 67 years, male, NA, stage:3, alive, 1290 days 43.6
DO45245 75 years, female, NA, stage:2, dead, 240 days 35.8
DO45205 67 years, female, NA, stage:2, dead, 90 days 33.3
DO23529 72 years, male, NA, stage:4, alive, 930 days 33.2
DO45289 78 years, female, NA, stage:3, alive, 360 days 30.1
DO45285 59 years, male, NA, stage:3, alive, 480 days 27.8
DO45297 61 years, female, NA, stage:4, dead, 1260 days 27.2
DO45211 76 years, male, NA, stage:3, alive, 240 days 22.6
DO45259 65 years, male, NA, stage:3, alive, 330 days 9.1
DO45299 70 years, female, NA, stage:1, alive, 1440 days 5.7
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
913 Tumor 1.7
444 Normal 1.6
223 Tumor 1.3
311 Tumor 1.2
823 Tumor 1.2
455 Tumor 1.2
917 Tumor 1.2
384 Normal 1.1
297 Tumor 1.1
421 Tumor 1.1
192 Normal 1.1
563 Tumor 1.0
536 Normal 1.0
535 Tumor 1.0
478 Normal 1.0
881 Tumor 0.9
1045 Tumor 0.9
498 Normal 0.9
145 Tumor 0.9
146 Normal 0.9
525 Tumor 0.8
185 Tumor 0.8
924 Normal 0.8
141 Tumor 0.7
975 Tumor 0.7
916 Normal 0.7
492 Normal 0.7
224 Normal 0.7
483 Tumor 0.7
925 Tumor 0.7
386 Normal 0.7
524 Normal 0.7
383 Tumor 0.7
213 Tumor 0.6
671 Tumor 0.6
817 Tumor 0.6
958 Normal 0.6
545 Tumor 0.6
538 Normal 0.6
433 Tumor 0.6
191 Tumor 0.6
922 Normal 0.6
874 Normal 0.6
574 Normal 0.6
312 Normal 0.6
354 Normal 0.6
672 Normal 0.6
137 Tumor 0.6
385 Tumor 0.5
375 Tumor 0.5
365 Tumor 0.5
785 Tumor 0.5
126 Normal 0.5
627 Tumor 0.5
641 Tumor 0.5
396 Normal 0.5
461 Tumor 0.5
558 Normal 0.5
857 Tumor 0.5
467 Tumor 0.5
187 Tumor 0.4
883 Tumor 0.4
984 Normal 0.4
228 Normal 0.4
921 Tumor 0.4
268 Normal 0.4
918 Normal 0.4
355 Tumor 0.4
188 Normal 0.4
195 Tumor 0.4
976 Normal 0.4
327 Tumor 0.4
448 Normal 0.4
982 Normal 0.3
284 Normal 0.3
516 Normal 0.3
468 Normal 0.3
395 Tumor 0.3
813 Tumor 0.3
697 Tumor 0.3
816 Normal 0.3
1042 Normal 0.3
553 Tumor 0.3
715 Tumor 0.3
884 Normal 0.3
138 Normal 0.3
392 Normal 0.3
394 Normal 0.3
1044 Normal 0.3
434 Normal 0.3
878 Normal 0.3
278 Normal 0.3
572 Normal 0.2
352 Normal 0.2
212 Normal 0.2
214 Normal 0.2
818 Normal 0.2
744 Normal 0.2
636 Normal 0.2
466 Normal 0.2
364 Normal 0.2
474 Normal 0.2
546 Normal 0.2
218 Normal 0.2
343 Tumor 0.2
914 Normal 0.2
415 Tumor 0.2
493 Tumor 0.2
923 Tumor 0.2
926 Normal 0.2
868 Normal 0.2
471 Tumor 0.2
148 Normal 0.1
978 Normal 0.1
814 Normal 0.1
526 Normal 0.1
432 Normal 0.1
722 Normal 0.1
628 Normal 0.1
344 Normal 0.1
427 Tumor 0.1
491 Tumor 0.1
528 Normal 0.1
314 Normal 0.1
388 Normal 0.1
328 Normal 0.1
515 Tumor 0.1
956 Normal 0.1
446 Normal 0.1
963 Tumor 0.1
698 Normal 0.1
211 Tumor 0.1
642 Normal 0.1
472 Normal 0.1
353 Tumor 0.1
135 Tumor 0.1
221 Tumor 0.1
786 Normal 0.1
162 Normal 0.1
1046 Normal 0.1
954 Normal 0.1
161 Tumor 0.1
721 Tumor 0.1
363 Tumor 0.1
716 Normal 0.0
514 Normal 0.0
412 Normal 0.0
968 Normal 0.0
447 Tumor 0.0
723 Tumor 0.0
852 Normal 0.0
866 Normal 0.0
332 Normal 0.0
196 Normal 0.0
864 Normal 0.0
172 Normal 0.0
142 Normal 0.0
877 Tumor 0.0
494 Normal 0.0
111 Normal 0.0
714 Normal 0.0
686 Normal 0.0
964 Normal 0.0
666 Normal 0.0
462 Normal 0.0
882 Normal 0.0
413 Tumor 0.0
362 Normal 0.0
136 Normal 0.0
416 Normal 0.0
488 Normal 0.0
662 Normal 0.0
738 Normal 0.0
696 Normal 0.0
615 Tumor 0.0
356 Normal -0.1
618 Normal -0.1
527 Tumor -0.1
912 Normal -0.1
456 Normal -0.1
713 Tumor -0.1
124 Normal -0.1
1032 Normal -0.1
262 Normal -0.1
217 Tumor -0.1
1028 Normal -0.1
778 Normal -0.1
342 Normal -0.1
867 Tumor -0.1
568 Normal -0.1
424 Normal -0.1
484 Normal -0.1
695 Tumor -0.2
756 Normal -0.2
286 Normal -0.2
387 Tumor -0.2
422 Normal -0.2
742 Normal -0.2
361 Tumor -0.2
376 Normal -0.2
298 Normal -0.2
534 Normal -0.2
567 Tumor -0.2
222 Normal -0.2
824 Normal -0.2
938 Normal -0.2
232 Normal -0.2
132 Normal -0.2
431 Tumor -0.2
1014 Normal -0.2
482 Normal -0.2
366 Normal -0.2
1022 Normal -0.2
858 Normal -0.2
341 Tumor -0.2
414 Normal -0.2
573 Tumor -0.2
477 Tumor -0.2
423 Tumor -0.2
554 Normal -0.2
664 Normal -0.3
272 Normal -0.3
277 Tumor -0.3
943 Tumor -0.3
464 Normal -0.3
944 Normal -0.3
114 Normal -0.3
1041 Tumor -0.3
331 Tumor -0.3
728 Normal -0.3
564 Normal -0.3
1015 Tumor -0.3
746 Normal -0.3
436 Normal -0.3
616 Normal -0.4
513 Tumor -0.4
952 Normal -0.4
367 Tumor -0.4
863 Tumor -0.4
777 Tumor -0.4
391 Tumor -0.4
368 Normal -0.4
617 Tumor -0.4
428 Normal -0.4
1031 Tumor -0.5
1026 Normal -0.5
128 Normal -0.5
473 Tumor -0.5
955 Tumor -0.5
966 Normal -0.5
862 Normal -0.5
518 Normal -0.5
425 Tumor -0.5
915 Tumor -0.5
983 Tumor -0.5
497 Tumor -0.5
443 Tumor -0.5
953 Tumor -0.5
1016 Normal -0.5
358 Normal -0.6
127 Tumor -0.6
452 Normal -0.6
873 Tumor -0.6
481 Tumor -0.6
537 Tumor -0.6
426 Normal -0.6
665 Tumor -0.6
533 Tumor -0.6
977 Tumor -0.7
186 Normal -0.7
261 Tumor -0.7
227 Tumor -0.7
267 Tumor -0.7
258 Normal -0.7
487 Tumor -0.8
463 Tumor -0.8
967 Tumor -0.8
741 Tumor -0.8
685 Tumor -0.8
1025 Tumor -0.8
1043 Tumor -0.8
517 Tumor -0.8
283 Tumor -0.9
571 Tumor -0.9
313 Tumor -0.9
911 Tumor -0.9
445 Tumor -0.9
557 Tumor -0.9
393 Tumor -0.9
285 Tumor -0.9
755 Tumor -1.0
411 Tumor -1.0
647 Tumor -1.0
271 Tumor -1.0
125 Tumor -1.0
113 Tumor -1.1
648 Normal -1.1
981 Tumor -1.1
727 Tumor -1.1
861 Tumor -1.1
147 Tumor -1.2
231 Tumor -1.2
1027 Tumor -1.2
745 Tumor -1.2
351 Tumor -1.2
435 Tumor -1.2
815 Tumor -1.2
112 Tumor -1.2
257 Tumor -1.2
465 Tumor -1.3
131 Tumor -1.3
937 Tumor -1.3
851 Tumor -1.4
957 Tumor -1.4
737 Tumor -1.4
523 Tumor -1.4
724 Normal -1.4
1021 Tumor -1.4
451 Tumor -1.5
965 Tumor -1.6
743 Tumor -1.6
865 Tumor -1.8
635 Tumor -1.8
171 Tumor -1.8
1013 Tumor -1.8
951 Tumor -1.9
357 Tumor -1.9
663 Tumor -2.0
123 Tumor -2.1
661 Tumor -2.3
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody CAB069456
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Carcinoma, Hepatocellular, NOS
Cholangiocarcinoma

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org